础濒锄丑别颈尘别谤鈥檚

KalGene gears up to manufacture and test promising 础濒锄丑别颈尘别谤鈥檚 treatment with NRC, McGill and CIMTEC

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel 础濒锄丑别颈尘别谤鈥檚 treatment in Canada that the parties have been co- developing since 2015.

The treatment, a biologic molecule made up of a peptide that fights 础濒锄丑别颈尘别谤鈥檚 and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.

Classified as: Montreal Neurological Institute, 础濒锄丑别颈尘别谤鈥檚, National Research Council of Canada, NRC, KalGene, Rosa-Neto, ranslational Neuroimaging, CIMTEC, Douglas Research Institute

Category:

Published on: 3 Oct 2016

鈥淏ig Data鈥� study discovers earliest sign of 础濒锄丑别颈尘别谤鈥檚 development

Research underlines importance of computational power in future neurological breakthrough

Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset 础濒锄丑别颈尘别谤鈥檚 disease (LOAD), identifying its first physiological signs.